$79.05
−2.67%Year over year
Reported trailing growth
- Revenue
- -0.1%
- EBITDA
- +11.5%
- EBIT
- +25.2%
- EPS
- +12.2%
- Free cash flow
- -14.5%
- Operating cash flow
- +20.8%
Forward estimates
Based on analyst estimates
- Revenue
- -35.1%
- EBITDA
- -31.6%
- EPS
- -20.2%
Three-year CAGR
- Revenue
- -6.0%
- EBITDA
- +2.5%
- EBIT
- +6.4%
- Net income
- -25.0%
- EPS
- -29.5%
- Free cash flow
- -12.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026